National Minority Quality Forum, Washington, DC
Kristen Stevens Hobbs, Thomas Farrington, Andrew McGlone, Roxanne Leiba Lawrence, Ginny Jacobs, Patrice Lazure, Pamela McFadden, Laura Lee Hall
Background: Black men are disparately affected by prostate cancer (PC). They are more likely to develop PC and at an earlier age when the disease is more advanced at diagnosis. As a result, Black men are two to three times more likely to die from PC than white men. Given these disparities, experts increasingly promote screening for PC in Black men at a younger age. Methods: To inform implementation of a quality improvement education (QIE) project in three primary care practices in Maryland, a zip code analysis of the prevalence of PC was performed. Maryland practices were selected due to higher rates of PC in regions of the state and significant Black populations (Table). The QIE initiative started with a baseline practice assessment survey (including information on panel size, patient demographics, PC screening/treatment approaches, and barriers) and an analysis of current PC screening rates. Health system leaders and champions from the practice sites received training on patient-centered conversations with high-risk Black patients and concerning QIE planning. The champions developed rapid cycle improvement plans to implement increased screening using a patient-oriented online educational platform (Dr. PSA), as well as posters, and placards for patient education. Results: The overall national prevalence of PC in Medicare Fee-for-Service Program beneficiaries in 2018 was 2.65%. For Black beneficiaries the overall prevalence was 2.89%. Prevalence for beneficiaries in specific Maryland zip codes are detailed in Table. *Data not available; Source: NMQF Prostate Cancer Index Baseline practice assessment data revealed that patient panels ranged from 4,000 to 58,163 patients, with Black patients accounting for 50% or more of two of the practices and 25 to 50% of the third practice. Barriers to screening identified include financial issues, insurance restrictions, and lack of knowledge about PC and screening. Baseline screening rates are approximately 75%. Conclusions: Zip code prevalence analysis and baseline practice assessment data confirmed the relevance of implementing a QIE initiative in the three selected sites. Through a mixed-methods evaluation study, practice staff knowledge, attitudes, and self-reported practices will be assessed pre- and post-QIE initiative to assess impact of the initiative and determine opportunities for further improvement in PC screening practices.
Zip Code | Medicare FFS Beneficiaries | Prevalence | ||||
---|---|---|---|---|---|---|
Total | Black | White | Total | Black | White | |
20706 | 2,109 | 1,617 | 492 | 3.75% | 3.71% | 3.86% |
20707 | 1,970 | 811 | 1,159 | 2.94% | 3.58% | 2.50% |
20716 | 2,449 | 1,402 | 1,047 | 2.04% | 2.35% | 1.62% |
20737 | 1,203 | 745 | 458 | 2.41% | 3.09% | *N/A |
20747 | 4,690 | 4,375 | 315 | 3.20% | 3.29% | *N/A |
20774 | 6,439 | 5,930 | 509 | 3.34% | 3.49% | *N/A |
21114 | 2,660 | 210 | 2,450 | 3.01% | *N/A | 2.94% |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2022 ASCO Quality Care Symposium
First Author: Ginny Jacobs
2024 ASCO Annual Meeting
First Author: Phuong Nhi Le
2024 ASCO Quality Care Symposium
First Author: Eunbee Cho
2023 ASCO Annual Meeting
First Author: Nicole Ann Gay